Moderna was recently told that the Health and Human Services Department (HHS) had withdrawn a $766million grant awarded by ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

Bernstein analysts reaffirmed their Market Perform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on May 20, following the company’s recently disclosed $6 billion licensing deal with ...

and more specifically for executive compensation. His career spans 6 decades, and his ability to strategically design compensation programs began when he was an HR leader at Pfizer. Mr. Ellig was ...

Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down as competition in the weight-loss drug space pressured the company's stock. "Considering the recent market challenges, the share price ...

Citing new information from British drugmaker GSK, U.S. lawmakers are pushing forward with a probe into a pandemic-era political controversy centered around the timing of trial results for Pfizer ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...